Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Completed · Phase 3

Conditions studied: Plaque Psoriasis

In brief

The objective of the study is to evaluate the safety and efficacy of a topical lotion.

Key facts

Study ID

NCT02462070

Run by

Bausch Health Americas, Inc.

People needed

203

Starts

2015-08-11

Expected to finish

2016-12-01

Last updated by the study team

2020-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 3 — Mobile, Alabama, United States
• Valeant Site 9 — Beverly Hills, California, United States
• Valeant Site 12 — Encino, California, United States
• Valeant Site 10 — San Diego, California, United States
• Valeant Site 1 — Santa Rosa, California, United States
• Valeant Site 16 — Denver, Colorado, United States
• Valeant Site 2 — Tampa, Florida, United States
• Valeant Site 7 — South Bend, Indiana, United States
• Valeant Site 8 — Louisville, Kentucky, United States
• Valeant Site 13 — Clinton Township, Michigan, United States
• Valeant Site 14 — Rochester, New York, United States
• Valeant Site 6 — Nashville, Tennessee, United States
• Valeant Site 5 — Austin, Texas, United States
• Valeant Site 4 — Houston, Texas, United States
• Valeant Site 11 — Norfolk, Virginia, United States
• Valeant Site 15 — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.